Literature DB >> 7843420

Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells.

G T Stavri1, Y Hong, I C Zachary, G Breier, P A Baskerville, S Ylä-Herttuala, W Risau, J F Martin, J D Erusalimsky.   

Abstract

Vascular endothelial growth factor (VEGF) mRNA expression was analysed in rabbit vascular smooth muscle cells following exposure to hypoxia and platelet-derived growth factor-BB (PDGF-BB). Hypoxia potently upregulated VEGF mRNA steady-state levels in a time- and concentration-dependent manner reaching a maximum level (approximately 30-fold increase) after 12-24 h at 0% 0(2). In contrast, PDGF-BB caused a modest increase in VEGF expression. However, the combination of PDGF-BB and a threshold hypoxic stimulus (2.5% O2 for 4 h) had a marked synergistic effect. Synergy between hypoxia and PDGF-BB was selective for VEGF expression as hypoxia had no effect on the PDGF-induced upregulation of the proto-oncogene c-myc. These results raise the possibility that hypoxia and PDGF-BB may act in concert to induce VEGF expression in the arterial wall during the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843420     DOI: 10.1016/0014-5793(94)01458-d

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling.

Authors:  Jiasheng Zhang; Teresa Silva; Timur Yarovinsky; Thomas D Manes; Sina Tavakoli; Lei Nie; George Tellides; Jordan S Pober; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

Review 4.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

Review 5.  Angiogenesis in transgenic models of multistep carcinogenesis.

Authors:  M G D' Angelo; T Afanasieva; A Aguzzi
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 6.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 7.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

8.  Angiogenic capacity and lung-colonizing potential in vivo is increased in weakly metastatic B16F1 cells and decreased in highly metastatic BL6 cells by phorbol esters.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

9.  Angiogenic factors in human proliferative sickle cell retinopathy.

Authors:  J Cao; M K Mathews; D S McLeod; C Merges; L M Hjelmeland; G A Lutty
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 10.  Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis.

Authors:  K P Claffey; G S Robinson
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.